COMP <GO>
FTRE vs ACHC // 10Y YIELD & FRED MACRO BETA
Fortrea Holdings Inc. (NASDAQ) VS. Acadia Healthcare Company Inc. (NASDAQ) • 15-METRIC TALLY: FTRE 2
— ACHC 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: ACHC
LAST: $21.29 (-7.97%) • MKT CAP: $2.05B
macro-sensitivity
0.99
LAST: $29.96 (+1.70%) • MKT CAP: $2.79B
macro-sensitivity
1.07
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTRE VS. ACHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTRE | ACHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -24.80% | -10.20 | ACHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.41% | -16.04% | +15.63 | FTRE | /fcf-yield <GO> |
| Operating Margin | -32.00% | -40.60% | +8.60 | FTRE | /operating-margins <GO> |
| Net Profit Margin | -36.30% | -33.30% | -3.00 | ACHC | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 5.00% | -4.00 | ACHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.45 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | ACHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 50.9 | -4.50 | ACHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.99 | 1.07 | -0.08 | ACHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 21.0x | +8.00 | ACHC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.05B | $2.79B | -$734.8M | ACHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTRE REV | ACHC REV | FTRE GROSS % | ACHC GROSS % | FTRE FCF | ACHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $3.31B | — | — | -$9.1M | -$439.9M |
| FY 2024 | $2.70B | $3.15B | — | — | $141.5M | -$560.7M |
| FY 2023 | $2.84B | $2.93B | — | — | $40.5M | $330.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTRE // BETA 0.99
ACHC // BETA 1.07